Related Experiment Video
Updated: Oct 18, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.4K
Long COVID-19 Pulmonary Sequelae and Management Considerations
Afroditi K Boutou1, Andreas Asimakos2, Eleni Kortianou3
1Department of Respiratory Medicine, "G. Papanikolaou" Hospital, 57010 Thessaloniki, Greece.
Journal of Personalized Medicine
|September 28, 2021
Summary
Long COVID-19 can cause lasting lung problems, affecting many survivors. This review details pulmonary issues, risk factors, and rehabilitation strategies for long COVID-19 patients.
Area of Science:
- Pulmonology
- Infectious Diseases
- Public Health
Background:
- COVID-19 pandemic has led to a global health crisis.
- Survivors of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and COVID-19 can experience long-term health issues.
- Long-term sequelae, termed long COVID-19 syndrome, affect multiple organs for up to six months post-infection.
Purpose of the Study:
- To review current knowledge on pulmonary manifestations of long COVID-19.
- To highlight clinical symptoms, parenchymal, and functional abnormalities.
- To discuss epidemiology, risk factors, follow-up, and management strategies.
Main Methods:
- Comprehensive literature review of studies on long COVID-19 pulmonary manifestations.
- Analysis of clinical data, epidemiological findings, and treatment outcomes.
- Synthesis of information on diagnostic and therapeutic interventions.
Main Results:
- A significant minority of COVID-19 survivors develop persistent pulmonary abnormalities.
- Long COVID-19 lung issues include diverse symptoms and functional deficits.
- Risk factors and effective follow-up strategies are being identified.
Conclusions:
- Pulmonary sequelae are a critical component of long COVID-19 syndrome.
- Early identification and personalized pulmonary rehabilitation are crucial for management.
- Further research is needed to fully understand and treat long COVID-19 lung complications.
More Related Videos
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.8K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
01:28Pneumonia IV: Management
503
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
503
01:26COPD: Management Using Bronchodilators and Corticosteroids
478
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
478
01:20COPD: Pathogenesis and Clinical Features
696
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
696
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.4K